Concepedia

Elliott Blackwood

EB

Statistics

Publications

3

Citations

386

H-Index

3

Active since

2020

Affiliations

Hospital of the University of Pennsylvania(Current)

The Wistar Institute

Inovio Pharmaceuticals (United States)

Alliance for Multispecialty Research (United States)

Elliott Blackwood is an author at Hospital of the University of Pennsylvania specializing in immunization, vaccine immunology, and vaccination.

ORCID

Publications per year

2020–2022

3

Publications

3

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 282 citations · Full text

, , +17

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes et al. · The Journal of Infectious Diseases · 2022 · 61 citations · Full text

, , +17

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen, Pablo Tebas, Joseph Agnes et al. · medRxiv · 2021 · 43 citations · Full text

, , +17

1–3 of 3